Neuroskeptic reviews the implications of the new/old interest in “dimensional” diagnosis in DSM-5 (which involves acknowledgment of symptoms across categories of diagnosis, rather than a strictly categorical approach), in light of DSM-5 task force chair David Kupfer’s financial interest in a company that provides such an assessment via computer. Kupfer and Robert Gibbons published an article on the method in JAMA Psychiatry, neglecting to mention the conflict of interest.
